Now showing items 1-2 of 2

    • Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma. 

      George, SL; Falzone, N; Chittenden, S; Kirk, SJ; Lancaster, D; Vaidya, SJ; Mandeville, H; Saran, F; Pearson, AD; Du, Y; Meller, ST; Denis-Bacelar, AM; Flux, GD (2016-05)
      Iodine-131-labelled meta-iodobenzylguanidine (I-mIBG) therapy is an established treatment modality for relapsed/refractory neuroblastoma, most frequently administered according to fixed or weight-based criteria. We evaluate ...
    • Pre-clinical quantitative imaging and mouse-specific dosimetry for 111In-labelled radiotracers. 

      Denis-Bacelar, AM; Cronin, SE; Da Pieve, C; Paul, RL; Eccles, SA; Spinks, TJ; Box, C; Hall, A; Sosabowski, JK; Kramer-Marek, G; Flux, GD (2016-12)
      BACKGROUND: Accurate quantification in molecular imaging is essential to improve the assessment of novel drugs and compare the radiobiological effects of therapeutic agents prior to in-human studies. The aim of this study ...